We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
251
Verition Fund Management
Connecticut
$264K +$284K +5,572 New
JIC
252
Johnson Investment Counsel
Ohio
$263K +$284K +5,581 New
RhumbLine Advisers
253
RhumbLine Advisers
Massachusetts
$257K +$277K +5,430 New
COI
254
Connable Office Inc
Michigan
$254K +$273K +5,371 New
FMII
255
Farmers & Merchants Investments Inc
Nebraska
$253K +$272K +5,350 New
SJL
256
Shayne & Jacobs LLC
Tennessee
$237K +$255K +5,000 New
GCP
257
GSA Capital Partners
United Kingdom
$235K +$253K +4,964 New
RW
258
Rand Wealth
Maryland
$235K +$253K +4,975 New
PFBT
259
Parkside Financial Bank & Trust
Missouri
$234K +$251K +4,935 New
AWMS
260
Advocacy Wealth Management Services
Georgia
$230K +$247K +4,859 New
BT
261
Beacon Trust
New Jersey
$227K +$244K +4,795 New
Northwestern Mutual Wealth Management
262
Northwestern Mutual Wealth Management
Wisconsin
$222K +$238K +4,683 New
CBOA
263
Commonwealth Bank of Australia
Australia
$218K +$234K +4,600 New
MCM
264
Maple Capital Management
Vermont
$216K +$233K +4,575 New
WS
265
Wedbush Securities
California
$214K +$231K +4,527 New
FBNAT
266
FirstMerit Bank N.A. Trustee
Ohio
$208K +$224K +4,402 New
I
267
IberiaBank
Louisiana
$204K +$220K +4,314 New
ONB
268
Old National Bancorp
Indiana
$201K +$217K +4,258 New
HSBC Holdings
269
HSBC Holdings
United Kingdom
$171K +$185K +3,626 New
TCOV
270
Trust Company of Vermont
Vermont
$163K +$176K +3,449 New
Acadian Asset Management
271
Acadian Asset Management
Massachusetts
$156K +$168K +3,301 New
BRWA
272
B. Riley Wealth Advisors
Florida
$134K +$144K +2,837 New
ST
273
Spot Trading
Illinois
$131K +$141K +2,763 New
FNBT
274
FineMark National Bank & Trust
Florida
$118K +$127K +2,498 New
Jones Financial Companies
275
Jones Financial Companies
Missouri
$112K +$121K +2,375 New
9 10
11
12 13

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.